Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.
[Page S5612]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SUBMITTED RESOLUTIONS
______
SENATE RESOLUTION 692--DESIGNATING SEPTEMBER 2020 AS ``NATIONAL
PROSTATE CANCER AWARENESS MONTH''
Mr. MENENDEZ (for himself, Mr. Crapo, Mr. Wyden, Mr. Markey, Mr.
Cardin, Mr. King, Mr. Blumenthal, Mr. Van Hollen, Mr. Coons, Mr.
Booker, and Mr. Hawley) submitted the following resolution; which was
referred to the Committee on the Judiciary:
S. Res. 692
Whereas more than 3,100,000 men in the United States are
living with prostate cancer;
Whereas 1 in 9 men in the United States will be diagnosed
with prostate cancer in their lifetimes and 1 in 41 men in
the United States will die from prostate cancer;
Whereas prostate cancer is the most commonly diagnosed non-
skin cancer and the second-leading cause of cancer-related
deaths among men in the United States;
Whereas the American Cancer Society estimates that, in
2020, 191,930 men will be diagnosed with, and more than
33,330 men will die of, prostate cancer;
Whereas 40.9 percent of newly diagnosed prostate cancer
cases occur in men under the age of 65;
Whereas the odds of developing prostate cancer rise rapidly
after age 50;
Whereas African-American men suffer from a prostate cancer
incidence rate that is significantly higher than that of
White men and have more than double the prostate cancer
mortality rate than that of White men;
Whereas having a father or brother with prostate cancer
more than doubles the risk of a man developing prostate
cancer, with a higher risk for men who have a brother with
the disease and the highest risk for men with several
affected relatives;
Whereas screening by a digital rectal examination and a
prostate-specific antigen blood test can detect the disease
at the earlier, more treatable stages, which could increase
the chances of survival for more than 5 years to nearly 100
percent;
Whereas only 31 percent of men survive more than 5 years if
diagnosed with prostate cancer after the cancer has
metastasized;
Whereas there are typically no noticeable symptoms of
prostate cancer in the early stages, making appropriate
screening critical;
Whereas, in fiscal year 2020, the Director of the National
Institutes of Health will support approximately $287,000,000
in research projects focused specifically on prostate cancer;
Whereas, in fiscal year 2020, Congress appropriated
$110,000,000 for the Prostate Cancer Research Program of the
Department of Defense;
Whereas ongoing research promises further improvements in
prostate cancer prevention, early detection, and treatment;
and
Whereas educating people in the United States, including
health care providers, about prostate cancer and early
detection strategies is crucial to saving the lives of men
and preserving and protecting families: Now, therefore, be it
Resolved, That the Senate--
(1) designates September 2020 as ``National Prostate Cancer
Awareness Month'';
(2) declares that steps should be taken--
(A) to raise awareness about the importance of screening
methods for, and treatment of, prostate cancer;
(B) to encourage research--
(i) to improve screening and treatment for prostate cancer;
(ii) to discover the causes of prostate cancer; and
(iii) to develop a cure for prostate cancer; and
(C) to continue to consider ways to improve access to, and
the quality of, health care services for detecting and
treating prostate cancer; and
(3) calls on the people of the United States, interest
groups, and affected persons--
(A) to promote awareness of prostate cancer;
(B) to take an active role in the fight to end the
devastating effects of prostate cancer on individuals,
families, and the economy; and
(C) to observe National Prostate Cancer Awareness Month
with appropriate ceremonies and activities.
____________________